Search

everythinglearnresearchcommunity

for

Search:↓

A blood pressure drug, diltiazem, may also help treat influenza.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Immune cells affect hair growth and could lead to new hair loss treatments.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

A girl with lupus had unusually long and thick eyelashes, a rare symptom of her condition.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

A cancer patient's hair became permanently curly after treatment with nivolumab.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Nilotinib can cause generalized keratosis pilaris.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Cetuximab can cause unusual hair growth and hair loss.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

The hexosamine pathway helps protect skin cells from stress and may improve skin and hair health.